Prevalence and cardiac phenotype of patients with a phospholamban mutation

Publication date

2019-02

Authors

Hof, Irene E
van der Heijden, Jeroen FISNI 0000000396634202
Kranias, E G
Sanoudou, D
de Boer, R A
van Tintelen, J. PeterORCID 0000-0003-3854-6749ISNI 0000000392212598
van der Zwaag, P A
Doevendans, PieterISNI 0000000110574516

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

Abstract

Pathogenic mutations in the phospholamban (PLN) gene may give rise to inherited cardiomyopathies due to its role in calcium homeostasis. Several PLN mutations have been identified, with the R14del mutation being the most prevalent cardiomyopathy-related mutation in the Netherlands. It is present in patients diagnosed with arrhythmogenic cardiomyopathy as well as dilated cardiomyopathy. Awareness of the phenotype of this PLN mutation is of great importance, since many carriers remain to be identified. Patients with the R14del mutation are characterised by older age at onset, low-voltage electrocardiograms and a high frequency of ventricular arrhythmias. Additionally, these patients have a poor prognosis often with left ventricular dysfunction and early-onset heart failure. Therefore, when there is a suspicion of a PLN mutation, cardiac and genetic screening is strongly recommended.

Keywords

Arrhythmogenic cardiomyopathy, Dilated cardiomyopathy, Phenotype, Phospholamban, Cardiology and Cardiovascular Medicine, Review, Journal Article

Citation

Hof, I E, van der Heijden, J F, Kranias, E G, Sanoudou, D, de Boer, R A, van Tintelen, J P, van der Zwaag, P A & Doevendans, P A 2019, 'Prevalence and cardiac phenotype of patients with a phospholamban mutation', Netherlands Heart Journal, vol. 27, no. 2, pp. 64-69. https://doi.org/10.1007/s12471-018-1211-4